openPR Logo
Press release

Biopharmaceutical Contract Manufacturing to Reach Over $25 Billion by 2027. Contract manufacturing of live-attenuated Vaccines gaining popularity - Arizton

According to latest research report, biopharmaceutical contract manufacturing market to grow at a CAGR of over 14% during 2022-2027. Contract manufacturing services serve as a strategy for various companies ranging from big pharma players to small specialty entities. Major factors driving the demand for contract manufacturers include continuous cost-cutting efforts, decreased time to market, growing specialty firms that lack in-house manufacturing facilities, and an increase in outsourcing activities. In recent years, pricing pressures have been driving contract manufacturers to increase their operations in the market.

Click Here to Download the Free Sample Report: https://www.arizton.com/request-sample/3485

VENDORS INSIGHTS
The emergence of several start-ups and emerging players intensified the competition among vendors. Major vendors offering biopharmaceutical contract manufacturing services are present in the region of North America, including small, mid-sized, or even large companies. Europe and APAC contain a few larger players and several small and mid-sized vendors. Emerging economies, such as China, India, Brazil, and Mexico, are likely to offer significant growth opportunities for players in the biopharmaceutical contract manufacturing market. With increasing competition and the emergence of several companies, major vendors are getting more active and are focusing on more diverse contract manufacturing services as required by end-users.

MARKET SEGMENTATION
Product Type
• Finished Dosage Form (FDF)
• Active Pharmaceutical Ingredients (APIs)
Biologics
• Monoclonal Antibodies (mAbs)
• Vaccines
• Others
Expression System
• Mammalian
• Non-Mammalian
Scale of Operations
• Commercial
• Research (Clinical & Preclinical)
Company Size
• Large & Very Large Companies
• Small & Mid-Sized Companies
Geography
• Europe
o Germany
o UK
o France
o Switzerland
o Italy
o Spain
• APAC
o China
o Japan
o South Korea
o Australia
o India
• North America
o US
o Canada
• Latin America
o Brazil
o Mexico
• Middle East & Africa
o Saudi Arabia
o UAE
o South Africa
o Turkey

Key Vendors
• Boehringer Ingelheim
• Lonza
• Samsung Biologics

Key Companies
• AbbVie
• Catalent
• Emergent BioSolutions
• FUJIFILM
• Merck KGaA
• Pfizer
• Serum Institute of India
• WuXi Biologics

Other Prominent Vendors
• AGC Biologics
• Ajinomoto
• Albany Molecular Research (AMRI)
• Asymchem
• Biocon
• Cobra Biologics
• Charles River Laboratories
• Goodwin Biotechnology
• KBI Biopharma
• Sanofi
• Bavarian Nordic
• Wacker Biotech B.V
• Jubilant HollisterStier
• National Resilience
• Novasep
• Kemwell Biopharma
• Midas Pharma
• Alcami
• Cambrex
• Pharmaceutics International
• Singota Solutions
• Thermo Fisher Scientific
• Binexc
• Canton Biologics
• ChemPartner
• Cytovance Biologics

To know more: https://www.arizton.com/market-reports/biopharmaceutical-contract-manufacturing-market

ABOUT ARIZTON:  

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services. 

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. 

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. 

Arizton Advisory and Intelligence
Call: +1-312-235-2040 
          +1 302 469 0707 

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Contract Manufacturing to Reach Over $25 Billion by 2027. Contract manufacturing of live-attenuated Vaccines gaining popularity - Arizton here

News-ID: 2752907 • Views: 211

More Releases from Arizton Advisory & Intelligence

Europe Data Center Colocation Market to Reach USD 11.8 Billion - Arizton
According to Arizton's latest research report, the Europe data center colocation market is projected to grow at a CAGR of 6.19% during 2022-2027. Several governments initiative is expected to promote data center investments, such as subsidies on procurement of land for data center development, renewable energy procurement, and electricity tariffs, will drive the European data center colocation market during the forecast period. The COVID-19 pandemic had a higher impact on
Industrial Workwear Market to Hit USD 51 Billion By 2027 - Arizton
Arizton advisory and intelligence announces publication of latest market research report on Industrial Workwear Market - Global Outlook & Forecast 2022-2027. With the rapid growth of industrial and service sectors in emerging economies, the size of the workforce is expected to rise. Therefore, the increasing awareness among corporates on the advantages of well-planned and organized workwear is anticipated to drive the acceptance of workwear. The industrial workwear market is expected
Virtual Clinical Trials Market to Record USD 5 Billion by 2027 - Arizton
According to Arizton's latest research report, the virtual clinical trials market is expected to grow at a CAGR of 18% during 2021-2027. The latest trends in the market are adopting the "Bring-Your-Own-Device" strategy, clinical trials powered with better data through newly connected devices, and the adoption of synthetic clinical trials. Virtual clinical trials constitute an innovative approach through remote monitoring and patient-centric approaches. The adoption of virtual clinical trials was
Australia Data Center Market to Witness Investment of USD 9.6 Billion by 2027. N …
According to Arizton's latest research report, the Australia data center market is to reach USD 9.6 Billion by 2027. In 2021, Sydney and Melbourne received 70% of Australia's overall data center investment. New data center investors such as Stockland and Trifalga have invested in the data centers in Sydney. Sydney is a significant data center market in Australia driven by factors such as growth in digitalization, connectivity options, and 5G

All 5 Releases


More Releases for Biologics

Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report. the
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off) The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025. Get Free Sample Copy of this Research
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to